Allogeneic hematopoietic cell transplant (HCT) in patients (pts) ≥ 60 years of age with first relapsed or refractory acute myeloid leukemia (R/R AML) after treatment with vosaroxin plus cytarabine (vos/cyt) vs placebo plus cytarabine (pla/cyt): Results from VALOR.

Refractory Acute Myeloid Leukemia ◽

Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission

Bone Marrow Transplantation ◽

10.1038/bmt.2015.59 ◽

2015 ◽

Vol 50 (7) ◽

pp. 907-913 ◽

Cited By ~ 11

Author(s):

F V Michelis ◽

E G Atenafu ◽

V Gupta ◽

D D Kim ◽

J Kuruvilla ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

De Novo ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Secondary Acute Myeloid Leukemia ◽

First Remission ◽

What is the role of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia?

Bone Marrow Transplantation ◽

10.1038/s41409-019-0584-3 ◽

2019 ◽

Vol 55 (2) ◽

pp. 325-331

Author(s):

Nour M. Moukalled ◽

Mohamed A. Kharfan-Dabaja

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Relapsed Acute Myeloid Leukemia ◽

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

Bone Marrow Transplantation ◽

10.1038/s41409-021-01450-3 ◽

2021 ◽

Author(s):

Antonio M. Jimenez Jimenez ◽

Marcos De Lima ◽

Krishna V. Komanduri ◽

Trent P. Wang ◽

Mei-Jie Zhang ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Risk Stratification ◽

Genetic Risk ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Prognostic Impact of Variant Allelic Frequency of Molecular Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) on Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.01.026 ◽

2017 ◽

Vol 23 (3) ◽

pp. S71

Author(s):

Betty Ky Hamilton ◽

Navneet S. Majhail ◽

Cassandra Hirsch ◽

Bartolmiej Przychodzen ◽

Lisa Rybicki ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Allelic Frequency ◽

Hematopoietic Cell ◽

Prognostic Impact ◽

Cell Transplant ◽

Improved Survival of Patients With Acute Myeloid Leukemia With Normal Cytogenetics and FLT3-ITD Mutation After Allogeneic Hematopoietic Cell Transplant: Concurrent NPM1 Mutation Not Associated With Better Outcomes

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2010.12.281 ◽

2011 ◽

Vol 17 (2) ◽

pp. S246

Author(s):

Y. Loh ◽

G.F. How ◽

W. Hwang ◽

Y.C. Linn ◽

Y.T. Goh ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Npm1 Mutation ◽

Normal Cytogenetics ◽

Acute Myeloid Leukemia and Allogeneic Hematopoietic Cell Transplant

Blood and Marrow Transplant Handbook ◽

10.1007/978-3-030-53626-8_15 ◽

2021 ◽

pp. 231-250

Author(s):

Curtis Lachowiez ◽

Rachel J. Cook

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Low-Dose Azacitidine (AZA) for Treatment of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapse after Allogeneic Hematopoietic Cell Transplant (HCT)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.11.610 ◽

2016 ◽

Vol 22 (3) ◽

pp. S212-S213 ◽

Cited By ~ 2

Author(s):

Masumi Ueda ◽

Hillard M. Lazarus ◽

Brenda Cooper ◽

Paolo Caimi ◽

Richard Creger ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Low Dose ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions

World Journal of Stem Cells ◽

10.4252/wjsc.v6.i2.69 ◽

2014 ◽

Vol 6 (2) ◽

pp. 69 ◽

Cited By ~ 18

Author(s):

Abraham S Kanate

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Future Directions ◽

Current State ◽

AML-262: Ivosidenib (IVO) Prior to Hematopoietic Cell Transplant (HCT) for Patients with IDH1-Mutant Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) Who Cannot Tolerate Intensive Chemotherapy (IC)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(20)30745-x ◽

2020 ◽

Vol 20 ◽

pp. S197-S198

Author(s):

Courtney D DiNardo ◽

Eytan M Stein ◽

Arnaud Pigneux ◽

Jessica K Altman ◽

Robert Collins ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Intensive Chemotherapy ◽

Refractory Acute Myeloid Leukemia ◽

Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remission

Leukemia & Lymphoma ◽

10.3109/10428194.2010.500431 ◽

2010 ◽

Vol 51 (9) ◽

pp. 1-6 ◽

Cited By ~ 6

Author(s):

Lisa Sproat ◽

Brian Bolwell ◽

Lisa Rybicki ◽

Shawnda Tench ◽

Josephine Chan ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Cell Transplant ◽

First Remission ◽